Showing results (1-10 of 111) with videos related to
Sort By:
Pageof 12
Expert Opinion on Drug Metabolism & Toxicology|December 3, 2014
Is bioavailability altered in generic versus brand anticonvulsants?Slobodan M Jankovic, Dragana Ignjatovic RisticTherapeutic Advances in Psychopharmacology|June 9, 2021
Prescription attitudes and practices regarding clozapine among Serbian psychiatrists: results of a nationwide surveyDragana Ignjatovic Ristic, Dan Cohen, Ivan RisticInternational Journal of Psychiatry in Medicine|July 28, 2023
Personality traits and attitude towards euthanasia among medical students in SerbiaIvan Ristic, Dragana Ignjatovic-Ristic, Tatjana GazibaraPsych Journal|September 16, 2021
HEXACO-60 Personality Trait Inventory: Psychometric characteristics in a sample of medical students from SerbiaIvan Ristic, Jelena Dotlic, Dragana Ignjatovic-Ristic, et al.Biomedical Reports|December 8, 2025
Clozapine (and norclozapine) concentrations are correlated with functioning, disability and side-effects when patients are treated with clozapine without the availability of therapeutic drug monitoring: A study of treatment-resistant schizophrenia inpatientsVeroljub Petrovic, Dan Cohen, Dragic Bankovic, et al.Iranian Journal of Public Health|July 24, 2023
The Influence of Sociodemographic Factors on the Level of Hope in Women with Breast CancerJagoda Gavrilovic, Marija Kovacevic, Dragana Ignjatovic Ristic, et al.Annals of General Psychiatry|December 4, 2013
Risk factors for lethal outcome in patients with delirium tremens - psychiatrist's perspective: a nested case-control studyDragana Ignjatovic-Ristic, Nemanja Rancic, Slobodan Novokmet, et al.Expert Opinion on Drug Metabolism & Toxicology|April 15, 2026
Clinically significant interactions between drugs, microbiome, and sexSlobodan M JankovicExpert Opinion on Drug Metabolism & Toxicology|July 5, 2014
Pharmacokinetics of selective β1-adrenergic blocking agents: prescribing implicationsSlobodan M JankovicJournal of Inflammation Research|November 19, 2011
Injectable interferon beta-1b for the treatment of relapsing forms of multiple sclerosisSlobodan M JankovicPageof 12